Form 144 - Report of proposed sale of securities:
SEC Accession No. 0000950170-24-016656
Filing Date
2024-02-16
Accepted
2024-02-16 20:11:01
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 2848
  Complete submission text file 0000950170-24-016656.txt   4195
Mailing Address
Business Address
PATTERSON LEONE D (Reporting) CIK: 0001233539 (see all company filings)

Type: 144

Mailing Address 171 OYSTER POINT BLVD., SUITE 500 SOUTH SAN FRANCISCO CA 94080
Business Address 171 OYSTER POINT BLVD., SUITE 500 SOUTH SAN FRANCISCO CA 94080 415-865-2066
Tenaya Therapeutics, Inc. (Subject) CIK: 0001858848 (see all company filings)

EIN.: 813789973 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-40656 | Film No.: 24650319
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)